Filing Details
- Accession Number:
- 0001209191-17-023960
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-31 19:41:33
- Reporting Period:
- 2017-03-29
- Filing Date:
- 2017-03-31
- Accepted Time:
- 2017-03-31 19:41:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 353569 | Quidel Corp | QDEL | In Vitro & In Vivo Diagnostic Substances (2835) | 942573850 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1406652 | C Douglas Bryant | 12544 High Bluff Drive, Suite 200 San Diego CA 92130 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-03-29 | 13,080 | $12.36 | 297,573 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-03-29 | 13,080 | $22.30 | 284,493 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-03-30 | 12,000 | $12.36 | 296,493 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-03-30 | 12,000 | $22.52 | 284,493 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-03-31 | 12,000 | $12.36 | 296,493 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-03-31 | 12,000 | $22.69 | 284,493 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Options | Disposition | 2017-03-29 | 13,080 | $0.00 | 13,080 | $12.36 |
| Common Stock | Non-Qualifed Stock Options | Disposition | 2017-03-30 | 12,000 | $0.00 | 12,000 | $12.36 |
| Common Stock | Non-Qualified Stock Options | Disposition | 2017-03-31 | 12,000 | $0.00 | 12,000 | $12.36 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 641,212 | 2013-02-02 | 2019-02-02 | No | 4 | M | Direct |
| 629,212 | 2013-02-02 | 2019-02-02 | No | 4 | M | Direct |
| 617,212 | 2013-02-02 | 2019-02-02 | No | 4 | M | Direct |
Footnotes
- The weighted average sale price for these transactions was $22.30 per share, with a range of $21.83 to $22.51 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
- The weighted average sale price for these transactions was $22.52 per share, with a range of $22.36 to $22.64 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
- The weighted average sale price for these transactions was $22.69 per share, with a range of $22.59 to $22.76 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price
Billionaire Hedge Funds
